Thenalidine
| Thenalidine | |
|---|---|
| Thenalidine.svg | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Thenalidine is a pharmaceutical drug that belongs to the class of antihistamines. It was developed in the mid-20th century and was primarily used for its antihistamine properties to treat allergic reactions and symptoms such as itching, sneezing, and runny nose.
Chemical Structure[edit]
Thenalidine is characterized by its unique chemical structure, which includes a thiazole ring. This structure is responsible for its ability to block histamine receptors in the body, thereby reducing the effects of histamine.
Pharmacology[edit]
Thenalidine works by inhibiting the action of histamine at the H1 receptor, which is a key mediator in allergic responses. By blocking these receptors, Thenalidine can alleviate symptoms associated with allergic rhinitis, urticaria, and other histamine-related conditions.
Uses[edit]
Thenalidine was used to treat a variety of allergic conditions, including:
- Allergic rhinitis
- Urticaria (hives)
- Conjunctivitis
Side Effects[edit]
Like many antihistamines, Thenalidine can cause side effects, which may include:
History[edit]
Thenalidine was introduced in the 1950s as part of a new wave of antihistamines. It was one of the early drugs in this class that provided relief from allergic symptoms without the severe sedative effects of earlier antihistamines.
